Evaluation of MRI for Prostate Cancer
NCT00930748 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2011-06-27
Summary
The objective of this study is to evaluate imaging quality and correlation with histopathology in prostate cancer.
Conditions
- Prostatic Neoplasms
Interventions
- DEVICE
-
MR imaging with endorectal coil
MR imaging with endorectal coil
- DEVICE
-
MRI with endo-rectal coil
MRI with endo-rectal coil
Sponsors & Collaborators
-
Sheba Medical Center
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-11-30
- Primary Completion
- 2011-06-30
- Completion
- 2011-06-30
Countries
- Israel
Study Locations
More Related Trials
-
Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma
NCT00230386 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer
NCT03697148 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning
NCT02470910 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy
NCT02312401 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer
NCT02483884 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
MRI With C13 Pilot Study Prostate Cancer
NCT02450201 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Using PSMA PET-CT as a Diagnostic Tool for Detection of Prostatic Cancer at an Early Stage
NCT04116086 ·Status: UNKNOWN ·Phase: NA
-
Multi-parametric Magnetic Resonance Imaging for Prostate Cancer Patients
NCT03180398 ·Status: TERMINATED ·Phase: NA
-
PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer
NCT04243941 ·Status: WITHDRAWN ·Phase: PHASE2
-
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
NCT01834001 ·Status: RECRUITING
-
MRI-Guided Biopsy of Recurrent Prostate Cancer After Radiotherapy
NCT00775866 ·Status: COMPLETED ·Phase: NA
-
MRI Guided Prostate Biopsy
NCT06302595 ·Status: RECRUITING ·Phase: NA
-
MRI Before Biopsy in Diagnosing Patients With Prostate Cancer
NCT02131207 ·Status: TERMINATED
-
Value of Ultra-fast Prostate MRI in Prostate Cancer
NCT05903781 ·Status: COMPLETED
-
F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in the Management of Primary and Recurrent Prostate Cancer
NCT00963755 ·Status: COMPLETED
-
PET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric Study
NCT05806853 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Prostate MRI Before Prostate Biopsies
NCT02485379 ·Status: COMPLETED ·Phase: NA
-
ConfirmMDx Assay in Multiparametric MRI (mpMRI) PIRADS Scored Lesions After a Negative MR/US Fusion Biopsy
NCT03597386 ·Status: WITHDRAWN
-
Advanced Imaging for Radiotherapy Treatment Planning and Guidance for Low-Intermediate Risk Prostate Cancer (Margin)
NCT00890006 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Comparison Study of PET/CT or PET/MRI Imaging to Magnetic Resonance Imaging (MRI) Alone in Men With Prostate Cancer
NCT03439033 ·Status: TERMINATED ·Phase: PHASE2
-
Multiparametric MRI in Men With Prostate Cancer Enrolled in Active Surveillance
NCT03648359 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Clinical Applications of Integrated PET/MR and PET/CT in the Diagnosis and Treatment of Prostate Cancer.
NCT06355843 ·Status: SUSPENDED ·Phase: NA
-
A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer
NCT01858688 ·Status: COMPLETED ·Phase: NA
-
68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU Therapy
NCT03949517 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Interest of Trimodality PET-CT Choline MRI Before Radiotherapy in High Risk Prostate Cancer
NCT03734757 ·Status: COMPLETED ·Phase: NA